TempoLife › Features › Hearing aids, amplifiers and what they cost here
Hearing aids, amplifiers and what they cost here
Hearing aids, amplifiers and what they cost here: the category is opaque on purpose, so the page states the legal difference between a medical-device…
This launch guide maps the topic, the source base and the practical questions. Check the linked official authority before acting on a rule, deadline, price or safety requirement.
What this guide covers
The category is opaque on purpose, so the page states the legal difference between a medical-device hearing aid, an over-the-counter amplifier and an earbud with a hearing feature, then prices each route in Estonia and Finland with the reimbursement rules and waiting times.
Item pages cover the styles and which loss each suits, why a fitting with real ear measurement is the difference between use and a drawer, features that matter against features that do not, rechargeable batteries, telecoil and hearing loops, wireless streaming, tinnitus masking, buying online, drying and care, and what the ACHIEVE trial found about hearing aids and cognitive decline. ~14 pages.
How to use it
Use Hearing aids, amplifiers and what they cost here to understand the inputs, units and assumptions before relying on an output. A useful result should be reproducible from the named source rather than presented as an unexplained score.
The page keeps the main question, its evidence base and its limits together in one canonical place. That makes it useful as a quick orientation and avoids splitting a broad subject into shallow pages before each narrower answer has enough verified material of its own.
Search vocabulary in four languages
Terminology changes across borders. These are example phrases people use for the same subject in Estonian, Finnish, Russian and English; they are included as a practical vocabulary aid, not as hidden keywords.
| Language | Example phrase |
|---|---|
| Estonian | kuuldeaparaat hind eestis |
| Finnish | kuulokoje kela korvaus |
| Russian | слуховой аппарат или усилитель звука |
| English | OTC hearing aids vs prescription |
Evidence and provenance
The evidence map below records the primary, official or openly licensed material chosen for this guide. It is deliberately visible so a reader can tell the difference between a rule published by an authority, a measured dataset and an editorial explanation.
Source: WHO World Report on Hearing (free), US FDA OTC hearing aid rule 21 CFR 800.30 (public domain), EU MDR classification rules (EUR-Lex, reusable), Tervisekassa assistive-device list and Kela guidance (official), ACHIEVE trial (Lancet 2023, cited). · checked 2026-09-09
Source names are preserved even where an authority changes its web address. No figure is added to this launch page unless it is already present in the cited source description or can be computed from a named dataset.
Scope and boundaries
YMYL. Wax, sudden loss and one-sided loss route to a clinician; this never grades a person's hearing.
Connected TempoLife guides
The following paths are the intentional hand-offs named in the brief. They keep adjacent subjects separate while making the next useful reference easy to find.
Seniors
Continue to the related TempoLife reference.
Brainhealth
Continue to the related TempoLife reference.
Why it belongs on TempoLife
/hearing, /seniors, /brainhealth.
Frequently asked questions
What does this guide cover?
The category is opaque on purpose, so the page states the legal difference between a medical-device hearing aid, an over-the-counter amplifier and an earbud with a hearing feature, then prices each route in Estonia and Finland with the reimbursement rules and waiting times. Item pages cover the styles and which loss each suits, why a fitting with real ear measurement is the difference between use and a drawer, features that matter against features that do not, rechargeable batteries, telecoil and hearing loops…
What evidence does it use?
WHO World Report on Hearing (free), US FDA OTC hearing aid rule 21 CFR 800.30 (public domain), EU MDR classification rules (EUR-Lex, reusable), Tervisekassa assistive-device list and Kela guidance (official), ACHIEVE trial (Lancet 2023, cited).
Where does this guide stop?
YMYL. Wax, sudden loss and one-sided loss route to a clinician; this never grades a person's hearing.
Turn the reference into a routine
TempoLife brings food, movement, sleep and everyday health habits into one private place when you want to track what happens next.